CD34+ cells for Cell and Gene Therapy Process Development.

In this interview Dr Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade 34+ cells for cell and gene therapy process development.

Read more

Recent Posts